Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03896737
What this trial is testing

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 401
Testing effectiveness (Phase 2)Study completedNCT00667615
What this trial is testing

Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Hodgkin's DiseaseLymphoma
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Study completedNCT04961359
What this trial is testing

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)

Who this might be right for
Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 75
Testing effectiveness (Phase 2)UnknownNCT06277674
What this trial is testing

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

Who this might be right for
Non-small Cell Lung Cancer
Guangzhou University of Traditional Chinese Medicine 20
Not applicableStudy completedNCT04416646
What this trial is testing

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Istituto Oncologico Veneto IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT00602797
What this trial is testing

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
University of Nebraska 20
Early research (Phase 1)UnknownNCT06043388
What this trial is testing

Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 100
Large-scale testing (Phase 3)UnknownNCT00725231
What this trial is testing

Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP

Who this might be right for
Peripheral T Cell Lymphoma, UnspecifiedAngioimmunoblastic LymphadenopathyExtranodal NK/T-cell Lymphoma
University of Göttingen 274
Not applicableLooking for participantsNCT07591337
What this trial is testing

SNRK & Vascular Endothelial Aging

Who this might be right for
Vascular Aging
Tianjin Medical University 180
Testing effectiveness (Phase 2)Study completedNCT00475280
What this trial is testing

"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients

Who this might be right for
Leukemia, Lymphoblastic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto 102
Large-scale testing (Phase 3)Study completedNCT02435173
What this trial is testing

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Common Variable Immunodeficiency (CVID), APDS / PASLI
Novartis Pharmaceuticals 37
Not applicableStudy completedNCT02025062
What this trial is testing

Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinomas (HNSCCs)
Assistance Publique - Hôpitaux de Paris 499
Not applicableStudy completedNCT02842229
What this trial is testing

Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

Who this might be right for
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple Myeloma+1 more
Celgene 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT01880567
What this trial is testing

Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
CCND1 PositiveCCND2 PositiveCCND3 Positive+4 more
M.D. Anderson Cancer Center 113
Testing effectiveness (Phase 2)Study completedNCT00137800
What this trial is testing

Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Dana-Farber Cancer Institute 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT03943901
What this trial is testing

Split-Dose R-CHOP for Older Adults With DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaDLBCLCancer
University of Wisconsin, Madison 27
Not applicableUnknownNCT05406154
What this trial is testing

Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years

Who this might be right for
Mantle Cell Lymphoma (MCL)
Peking University Third Hospital 60
Large-scale testing (Phase 3)Study completedNCT01257139
What this trial is testing

Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments

Who this might be right for
Non Small-cell Lung Cancer
Rennes University Hospital 490
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07821242
What this trial is testing

Nimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck CancerRadiotherapy
Ke Hu 46
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Next Page